BAK Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

FY2025Q4

17.32B

-9.55%

-1.178

+397.82%

0.00

-100%

-1.382

-32.36%

Estimates Revision

The market is revising Downward the revenue expectations for Braskem S.A. (BAK) for FY2025, with the revenue forecasts being adjusted by -2.91% over the past three months. During the same period, the stock price has changed by 20.78%.

Revenue Estimates for FY2025

Revise Downward

-2.91%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-5.12%

In Past 3 Month

Stock Price

Go Up

+20.78%

In Past 3 Month

3 Analyst Rating

Wall Street analysts forecast BAK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BAK is 3.30 USD with a low forecast of 2.80 USD and a high forecast of 3.80 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

2 Hold

1 Sell

Moderate Sell

Current: 0.000

Low

2.80

Averages

3.30

High

3.80

Current: 0.000

Low

2.80

Averages

3.30

High

3.80

BofA

Neutral

downgrade

2025-12-23

Reason

BofA

Price Target

2025-12-23

downgrade

Neutral

Reason

BofA lowered the firm's price target on Braskem to $3.30 from $3.70 and keeps a Neutral rating on the shares after the Brazilian President sanctioned the Draft Bill (PL) 892/2025, which establishes the PRESIQ benefit and the REIQ's rate schedule, but vetoed the proposed increase in REIQ for 2026. The firm had already incorporated the benefits of the increase in REIQ for 2026 and the Presiq for 2027-31, so it therefore sees the news as negative, the analyst tells investors.

Grupo Santander

Neutral -> Underperform

downgrade

$2.80

2025-10-15

Reason

Grupo Santander

Price Target

$2.80

2025-10-15

downgrade

Neutral -> Underperform

Reason

Grupo Santander downgraded Braskem to Underperform from Neutral with a $2.80 price target.

UBS

Buy -> Neutral

downgrade

2025-09-26

Reason

UBS

Price Target

2025-09-26

downgrade

Buy -> Neutral

Reason

UBS downgraded Braskem to Neutral from Buy with a price target of $3.80, down from $5.10. The firm sees a tough backdrop for spreads, including a deterioration in the short-term outlook. UBS is more conservative on shares of Braskem as it sees no easy path to ceasing its cash consumption without a potential asset sale.

JPMorgan

Neutral

downgrade

$6 -> $5

2025-08-27

Reason

JPMorgan

Price Target

$6 -> $5

2025-08-27

downgrade

Neutral

Reason

JPMorgan lowered the firm's price target on Braskem to $5 from $6 and keeps a Neutral rating on the shares.

Bradesco BBI

Outperform -> Neutral

downgrade

2025-05-11

Reason

Bradesco BBI

Price Target

2025-05-11

downgrade

Outperform -> Neutral

Reason

Bradesco BBI downgraded Braskem to Neutral from Outperform with a $4 price target.

Valuation Metrics

The current forward P/E ratio for Braskem SA (BAK.N) is -1.41, compared to its 5-year average forward P/E of -8.57. For a more detailed relative valuation and DCF analysis to assess Braskem SA 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-8.57

Current PE

-1.41

Overvalued PE

26.60

Undervalued PE

-43.73

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

6.69

Current EV/EBITDA

9.59

Overvalued EV/EBITDA

9.37

Undervalued EV/EBITDA

4.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.24

Current PS

0.08

Overvalued PS

0.36

Undervalued PS

0.13

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

BAK News & Events

Events Timeline

No data

News

8.5

01-09Businesswire

PinnedQube Research Discloses 1% Stake in Bakkavor Group PLC

8.5

01-07Yahoo Finance

Qube Research Discloses 1% Stake in Bakkavor Group PLC

8.5

2025-12-15SeekingAlpha

Braskem Gains Ground as Novonor Moves Forward with Stake Sale Negotiations

People Also Watch

Frequently Asked Questions

What is Braskem SA (BAK) stock price today?

The current price of BAK is 3.08 USD — it has increased 5.48 % in the last trading day.

What is Braskem SA (BAK)'s business?

Braskem SA is a Brazil-based integrated petrochemical company for the first and second generation of thermoplastic resins. The Company's activities are divided into three operational segments: Brazil; the United States and Europe; and Mexico. The Brazil segment is focused on the production of polyethylene (PE), polypropylene (PP) and polyvinylchloride (PVC) resins, in addition to basic chemical inputs such as ethylene, propylene, butadiene, benzene, toluene, chlorine, soda, and solvents, among others. The United States and Europe segment is responsible for the production of polypropylene in units in the United States and Germany. The Mexico segment consists of the operation of ethylene cracker and polyethylene units located in Mexico.

What is the price predicton of BAK Stock?

What is Braskem SA (BAK)'s revenue for the last quarter?

Braskem SA revenue for the last quarter amounts to 3.18B USD, decreased -17.18 % YoY.

What is Braskem SA (BAK)'s earnings per share (EPS) for the last quarter?

Braskem SA. EPS for the last quarter amounts to -0.01 USD, decreased -92.31 % YoY.

What changes have occurred in the market's expectations for Braskem SA (BAK)'s fundamentals?

How many employees does Braskem SA (BAK). have?

Braskem SA (BAK) has 8569 emplpoyees as of January 10 2026.

What is Braskem SA (BAK) market cap?

Today BAK has the market capitalization of 1.22B USD.